Faron Pharmaceuticals Oy (LON:FARN) Shares Cross Above 50 Day Moving Average - Here's Why

Faron Pharmaceuticals Oy (LON:FARN - Get Free Report)'s stock price crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 177.48 ($2.29) and traded as high as GBX 190 ($2.45). Faron Pharmaceuticals Oy shares last traded at GBX 185 ($2.39), with a volume of 9,756 shares trading hands.

Faron Pharmaceuticals Oy Stock Performance

The company has a debt-to-equity ratio of 922.55, a current ratio of 1.45 and a quick ratio of 1.09. The firm has a fifty day simple moving average of GBX 177.37 and a 200 day simple moving average of GBX 185.68. The company has a market capitalization of £258.26 million, a price-to-earnings ratio of -5.14 and a beta of 0.36.

Faron Pharmaceuticals Oy Company Profile

Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.